v3.22.4
Restructuring Actions (Tables)
12 Months Ended
Dec. 31, 2022
Restructuring and Related Activities [Abstract]  
Schedule of restructuring and related costs The related restructuring charges for periods presented were recorded in the income statement as follows:
(Millions)202220212020
Cost of sales$$19$51
Selling, general and administrative expenses128879
Research, development and related expenses6177
Total operating income impact$18$124$137
The business segment operating income impact of these restructuring charges is summarized as follows:
202220212020
(Millions)Employee-RelatedEmployee-RelatedEmployee RelatedAsset-Related and OtherTotal
Safety and Industrial$2$30$36$7$43
Transportation and Electronics424161228
Health Care22123326
Consumer2710111
Corporate and Unallocated842161329
Total Operating Expense$18$124$101$36$137
The divestiture-related restructuring actions were recorded in the income statement as follows:
(Millions)2022
Cost of sales$3
Selling, general and administrative expenses36
Research, development and related expenses2
Total operating income impact$41
Schedule of restructuring reserve by type of cost
Restructuring actions, including cash and non-cash impacts, follow:
(Millions)Employee-RelatedAsset-Related and OtherTotal
Expense incurred in the fourth quarter of 2020$101 $36 $137 
Non-cash changes— (36)(36)
Accrued restructuring action balances as of December 31, 2020101 — 101 
Incremental expense incurred in 2021124 — 124 
Cash payments(127)— (127)
Adjustments(11)— (11)
Accrued restructuring action balance as of December 31, 202187  87 
Incremental expense incurred in the first quarter of 202218  18 
Cash payments(84) (84)
Adjustments(9) (9)
Accrued restructuring action balances as of June 30, 2022$12 $ $12 
Divestiture-related restructuring actions, including cash impacts, follow:
(Millions)Employee-Related
Expense incurred in the third quarter of 202241 
Cash payments(31)
Accrued restructuring action balances as of December 31, 2022
$10 
The divestiture-related restructuring actions were recorded in the income statement as follows:
(Millions)2020
Cost of sales$42 
Selling, general and administrative expenses12 
Research, development and related expenses
Total operating income impact$55 
Divestiture-related restructuring actions, including cash and non-cash impacts, follow:
(Millions)Employee-RelatedAsset-Related and OtherTotal
Expense incurred in the second quarter of 2020$32 $23 $55 
Non-cash changes— (14)(14)
Cash payments(14)— (14)
Adjustments(3)— (3)
Accrued restructuring action balance as of December 31, 202015 24 
Cash Payments(5)— (5)
Adjustments(1)— (1)
Accrued restructuring action balance as of June 30, 2021$$$18 
The restructuring charges were recorded in the income statement as follows:
(Millions)2020
Cost of sales$13 
Selling, general and administrative expenses37 
Research, development and related expenses
Total operating income impact$58 
The business segment operating income impact of these restructuring charges is summarized as follows:
2020
(Millions)
Employee-RelatedAsset-Related and OtherTotal
Safety and Industrial$$— $
Transportation and Electronics11 — 11 
Health Care12 — 12 
Consumer— 
Corporate and Unallocated— 23 23 
Total Operating Expense$35 $23 $58 
Restructuring actions, including cash and non-cash impacts, follow:
(Millions)Employee-RelatedAsset-RelatedTotal
Expense incurred in the second quarter of 2020$35 $23 $58 
Non-cash changes— (23)(23)
Cash payments(2)— (2)
Adjustments(9)— (9)
Accrued restructuring action balances as of December 31, 202024 — 24 
Cash Payments(4)— (4)
Adjustments(9)— (9)
Accrued restructuring action balances as of March 31, 2021$11 $— $11